Acute renal failure, costs of care, mortality, multiple organ failure, quality of life
Introduction
Prognosis remains poor for intensive care patients in ARF despite advances in renal supportive therapies, presumably since this reflects one aspect of MOF. This study examines the costs, longer-term outcome (5-year) and QOL in patients requiring RRT in the ICU.
Methods
• Retrospective observational cohort study of 23-bed multidisciplinary ICU in Finland
• 2 year period of ICU admissions (1992) (1993) • Outcomes in patients who required RRT: mortality, quality of life in survivors at 6 months following ICU discharge (Nottingham Health Profile and ADL index), and ICU costs (calculated from individual patient's TISS scores)
• Exclusions: patients with end-stage renal failure
Results
• Of 3447 patients, 69 (2%) required RRT. The cohort included 885 neurosurgical patients (none required RRT), and 1611 cardiac surgery patients (19 required RRT).
• ICU mortality 34%, hospital mortality 45%, 6-month mortality 55%, 5-year mortality 65%.
• ARF in conjunction with MOF occurred in 71%.
• Overall length of stay in the ICU was the same for survivors and non-survivors, although survivors had a significantly shorter ICU stay prior to RRT.
• Cost per ARF 6-month survivor was $80 000.
• Response to mailed QOL questionnaires was 50%, and loss of energy and limited physical mobility were the major complaints. In total 36% were dependent on external help for heavy housework.
